We are enrolling volunteers aged 55 or over who struggle with falling or staying asleep as well as waking up at night to urinate for our latest insomnia and nocturia research study.
The World Health Organization includes migraines as one of the 10 most debilitating medical conditions in the world affecting over 37 million in the U.S. alone. Accellacare has multiple options available to participate in migraine trials.
The World Health Organization includes migraines as one of the 10 most debilitating medical conditions in the world affecting over 37 million in the U.S. alone. Accellacare is enrolling a research study evaluating an investigational preventive treatment of migraine in children and teens ages 6 – 17.
Accellacare offers research participation options for those with MS such as; advancing current treatments, finding new therapies, and addressing associated symptoms.
Accellacare is enrolling a research study evaluating an investigational medication for Parkinson's disease. Eligible participants will receive study-related care and study medication at no cost.
The World Health Organization includes migraines as one of the 10 most debilitating medical conditions in the world affecting over 37 million in the U.S. alone. Accellacare has multiple options available to participate in migraine trials.
The World Health Organization includes migraines as one of the 10 most debilitating medical conditions in the world affecting over 37 million in the U.S. alone. Accellacare is enrolling a research study evaluating an investigational preventive treatment of migraine in children and teens ages 6 – 17.
This one-visit research study is evaluating blood samples collected from those with various types of thyroid/autoimmune diseases. Results will aid in understanding biomarkers associated with autoimmune thyroid diseases.
This one-visit research study is evaluating blood samples collected from those with various types of thyroid/autoimmune diseases. Results will aid in understanding biomarkers associated with autoimmune thyroid diseases.
Accellacare is enrolling a research study evaluating an investigational medication for agitation associated with Alzheimer's disease. Eligible participants will receive study-related care and study medication at no cost.
This one-visit research study is evaluating blood samples collected from those with various types of thyroid/autoimmune diseases. Results will aid in understanding biomarkers associated with autoimmune thyroid diseases.
Accellacare is enrolling adults who display COVID-19 symptoms, but are not at risk for severe illness. Eligible participants will receive study-related care and medication at no cost. Financial compensation will also be provided for time and travel expenses.
Accellacare is enrolling adults for a vaccine research study. Eligible participants will receive study-related care and study vaccine at no cost. Financial compensation will also be provided for time and travel expenses.
Accellacare is enrolling a research study for current e-cigarettes, vape, Juul, e-pen users to evaluate an ENDS. Eligible participants will receive financial compensation of for time and travel and access to ENDS for the duration of the study.
Accellacare provides options for health adults over 18 to be a part of medical advancements. Eligible participants will receive study-related care and financial compensation for time and travel.
Accellacare saw a need for a patient feedback and engagement program that gives patients a voice directly to the industry, to help create a truly patient-centric clinical research environment. The answer was The Patient Voice program.
Know someone who may benefit from research participation? Provide your referrals* below and we will contact them about their volunteer options. If they qualify, you will receive a gift card as a thank you.
Join us in celebrating the transformative power of communication through Makaton.
We use cookies on this website
We use necessary cookies which need to be on, to make sure our website functions properly and securely. By clicking "Accept all", you agree to the storing of cookies on your device to assist with our marketing efforts, site navigation and site usage analysis. Please view our cookie policy for further details
Cookies are used on web sites to store or retrieve information within your browser. Cookies may contain information about you, your preferences and/or your device. Without some cookies the site will fail to work correctly. Cookies are not used to directly identify you usually, but can personalise your web site visit. You can choose not to allow some types of cookies by opening the different sections below. Blocking some types of cookies may impair the web site operation or reduce the services we offer. More information
Manage Consent Preferences
These cookies are switched on and are needed for the website to work. For example they would be used to record your privacy preferences, or assist with optimising image display. You can set your browser to stop these cookies, but the site will not then work correctly. These cookies do not store any information that can identify you.
This website uses Google Analytics to count visits and analyse web traffic so we can monitor and improve the web site we present to you. We can work out which pages are liked most and least. The information these cookies collect is anonymous. Blocking these cookies will prevent us from monitoring your visit.
These cookies are used to provide enhanced functionality and personalisation. These are usually set by third parties who provide services on this web site, but some may be set by us. Blocking these cookies may prevent these services from working properly.